He holds a BA from Cornell University and a PhD in Virology from Harvard University. Nadim has 11+ years experience in commercializing drug discovery across diverse indications and modalities. Robert also led the Sequencing Operations and Technology Development groups at the Broad for over 12 years, implementing industrial process control methods, developing multiple generations of high-throughput DNA sequencing technologies, and establishing an agile learning culture in the organization. He holds a BS in Computer Science from The University of California, San Diego, and worked previously as a Software Engineer at IBM and Fidelity Investments. He co-created Rutberg's summits, including the flagship Wireless Influencers, and hosted. Sophie was a principal investigator in the Early Phase Trials Team at GSTT and has extensive experience in the delivery of early to late phase oncology trials. Angela has a BA in Pre-Medicine and French Studies from the University of Minnesota. Prior to joining RA, Emily was Chief Business Officer of Prevail Therapeutics from the companys inception in 2017 until its acquisition by Eli Lilly in 2021. Sadik Kassim is a scientist and executive with extensive experience in the biotechnology industry with a specific focus on cell and gene therapy bioprocessing and translational research. Cony D'Cruz is a Venture Partner at RA Ventures. Ramin is an experienced clinical trialist and previously led global clinical development programs at Akebia Therapeutics and Gilead Sciences. Becca has a BA in Biology from Colgate University and a PhD in Biology from MIT. Monica holds a BSc in Neuroscience and Pharmacology from the University of Toronto and a PhD in Cancer Biology from MIT. Prior to Sage, he had a 14-year tenure at Biogen in various business and commercial roles. Sonia has a BA in Chemistry and a PhD in Bioengineering, both from the University of Pennsylvania. Camerons primary responsibility is to conduct research and analysis for competitive landscapes of drugs and medical devices across a range of disease indications and capabilities. Patrick was instrumental to building Constellations discovery platform, establishing a portfolio of competitive clinical candidates and drove the maturation of the companys development efforts, leading to one PhIII and two PhII assets and three additional clinical candidates. Sophie led the cell therapy program, working with teams across the Trust to build capabilities to deliver industry and academically sponsored complex cell therapy trials for solid tumor cancer patients. RAJEEV SHAH Managing Partner ANDREW LEVIN, MD/PhD Partner and Managing Director JOSH RESNICK, MD Senior Managing Director PETER BALOGH Analyst GUNES BOZKURT, PhD Analyst TESS CAMERON Principal NATE DAVIS Analyst DEREK DiROCCO, PhD Partner CRISTINA GHENOIU, PhD Principal MICHAEL GILLESPIE, MD Analyst MATTHEW HAMMOND, PhD, MBA Principal More recently, Scott founded MissionGBM, a global community and resource focused on advancing brain cancer therapeutics development and care delivery. He served on the Scientific Advisory Boards of multiple companies including DNA Script, Danaher Life Sciences, and CircBio. Prior to RAVen, Scott was President and Managing Director of The Branta Group LLC, a healthcare company formation, capital investment, and strategic advisory firm known for taking an active management role with its clients and portfolio companies in the biotechnology, medical device, diagnostics, venture capital, and private equity sectors. Dings primary responsibility at RA Capital is to help guide internal software development to support competitive landscapes of drugs and medical devices across a range of disease indications and capabilities. Michael has more than two decades of experience in immuno-oncology and immunology research in both large pharma and biotech settings. Wing Venture Capital Oct 2018 - Present4 years 8 months Palo Alto, California Daily Wing Briefing - https://www.wing.vc/wing-briefing Managing Director and Head of Research Rutberg & Company. Most recently, David served as Director of Operations at Corbin Capital Partners, LP. Prior to MRL Ventures, Josh was a Venture Partner with Atlas Venture and a Partner at Prism Venture Partners, focusing on company formation and seed and Series A investing. Kavita Gupta, the founding managing partner at the crypto-focused Delta Blockchain Fund, told Fortune that at the height of the bull market, her fund was up 600%, buoyed by its token investments . Jaimie previously held roles in non-profit and medical settings and worked at Goldman Sachs where she was an Executive Assistant. Sadik holds a bachelor of science degree in Cell and Molecular Biology from Tulane University, and earned his PhD in Microbiology and Immunology from Louisiana State University. Prior to BEV, Kyle was a Principal at In-Q-Tel, the strategic investment arm of the CIA and US Intelligence Community, where he invested in early stage manufacturing, materials, energy, computing, and defense companies. Cosmas received his BS in Physics from Massachusetts Institute of Technology and his MD from Rutgers-New Jersey Medical School. Michael is the Chief Financial Officer at RA Capital Management. Rajeev is also Director at GPSK Investment Group, a proprietary trading and investment management firm active in India's financial markets. Brian is a IT Operations Manager at RA Capital Management. The Caixin BBD New Economy Index (NEI) came in at 30.1 last month, indicating that monitored new economy industries accounted for 30.1 . Her primary responsibility is leading and executing full cycle recruiting across all newcos and portfolio companies. Jennas primary responsibility at RA Capital is to create competitive landscapes of drugs and medical devices for disease indications and capabilities. . Rajeev's daily email, the Wing Briefing, features an expert curation of the day's top news in tech and venture capital. Breanna's primary responsibilities at RA are to work closely with the Investment Team to originate conviction in potential investments by identifying breakthroughs and putting data into context and to advise RA's portfolio companies on many aspects of program and pipeline strategy. He previously served as the CFO of Research Alliance Corp I before its merger with Point Biopharma and served on the boards of Research Alliance Corp I and Research Alliance Corp II. Candice Galvez is an Executive Assistant at RA Capital Management. Lorena's primary responsibility is to oversee all accounting related activities for the firm. Kat Riesen is the VP, Finance at RA Ventures (RAVen). Erin Clutter is the Head of Graphics at RA Capital Management. in Mechanical & Aerospace Engineering from Sharif University of Technology, Tehran, Iran and a PhD in Molecular Engineering from Pritzker School of Molecular Engineering, University of Chicago. Sophie received her doctorate in CAR T cell therapy from Kings College London, her pre-clinical medical degree from St Johns College, University of Oxford, and her clinical medical degree from Imperial College London, where she won the Norman C Lake prize for Surgery. RA Capital makes no guarantees as to their accuracy or completeness. Prior to joining RA, Kathryn was SVP of Strategy at Energetic Insurance where she addressed regulatory-driven commercial lender limitations to enable financing for renewable energy and efficiency via financial insurance products. Nandita has also held strategic and group head roles in the Novartis Preclinical Investigative Toxicology organization. Ryan Russell is a Fund Accountant at RA Capital Management. Receptionist and Facilities Administrator. He has over 20 academic publications, inventorship on numerous patents, and serves as reviewer for multiple journals and NIH grants committee. In this role, he will work to evaluate and incubate early-stage therapeutic programs. Sris primary responsibility at RA Capital is to help guide internal software development to support competitive landscapes of drugs and medical devices across a range of disease indications and capabilities. Habib Dable is a Venture Partner at RA Ventures (RAVen), focusing on advising and supporting newcos, portfolio companies and executives within RAVen. He is a respected biotech leader with over twenty years of biopharma experience across global organizations. venture capitalism. Prior to RA Capital, Tom worked as an Associate at Flagship Pioneering. Mike earned his MBA from the Darden Graduate School of Business Administration. in Life Science from National Taiwan University, M.S. She was also an Entrepreneurial Fellow at VentureLabs for Flagship Pioneering. He completed his residency in internal medicine at Yale-New Haven Hospital and completed his clinical gastroenterology fellowship at Massachusetts General Hospital / Harvard Medical School as well post-doctoral training with Frederick Alt, an HHMI investigator, in molecular immunology. Prior to joining biotech/pharma, she was a specialist in the corporate finance team at McKinsey & Co, focused on corporate transactions. Investopedia defines venture capital as a form of private equity financing that investors give to startups and small businesses they believe have long-term growth potential. Milind attended the residential Executive Program at The Wharton School of Management. Most recently, Brian served as Analyst, Biotech/Pharma/Specialty Pharma at Tamarack Capital Management. Most recently, Joe led the administration and support of all Apple products at Curriculum Associates as an IT Systems Engineer. Michael Ryan is an EIR at RA Capital. Prior to RA, Laura was a Principal at MP Healthcare Venture Management. Brian's primary responsibility at RA Capital is to manage the firm's IT Operations needs. Ben holds a BS in Biology and an MS in Virology from the University of Nebraska, Lincoln, and a PhD in Cancer Biology from the Tufts University School of Medicine. Gabe Fox is an Associate with the TechAtlas division of RA Capital Management. Alyssa holds a BS in Biochemistry from the University of California, Santa Barbara, and a PhD in Biochemistry from MIT. His prior posts include Fund Accountant at Nautic Partners and HLM Venture Partners. Her primary responsibilities are to support our Venture Team by coordinating management agendas, calendars, and external events. Her primary responsibilities are to provide strategic administrative support and to assist the co founder in various external and internal projects She previously held Senior Executive Assistant roles at Genuity Science and Charles River Laboratories, and served as Director of Operations at Gloucester Graphics, Inc. Amber has a dual BA concentration in International Business & Modern Languages from Northeastern University and studied abroad at American University of Paris. BioVentures. Cristina holds a Bachelor of Arts in Biochemistry from Mount Holyoke College and a PhD in Cell Biology and Epigenetics from Cornell University and The Rockefeller University. Prior to co-founding Therapeutics Alliances, Nadim worked in NYUs Industrial Liaison technology transfer group, and was a Research Analyst at the International AIDS Vaccine Initiative. Peter conducts due diligence on biotechnology companies at RA Capital, and advises RA's portfolio companies on many aspects of program and pipeline strategy. Daniel Grau, an experienced biotech entrepreneur and operating executive, currently serves as CEO and Director at Avilar Therapeutics, a leading extracellular protein degradation company. Jessica manages RA's Innovator Resources and co-founded RApport, our biotech communications platform. Currently, he serves as Chief Technology Officer at Danaher, with a focus on new genomic medicines. Eric holds a MAcc from Bentley University and a BS in Finance from George Mason University. Robert Nicol is a Venture Partner at RA Ventures (RAVen), focusing on company creation. Alonso completed his Ph.D. in Chemistry at the University of Florida and his post-doctoral work as a Howard Hughes Medical Institute Fellow at Harvard University and the Massachusetts General Hospital. Emily Gransky is VP of Recruiting at RA Ventures (RAVen). Prior to that, he was a Life Sciences Investment Associate at Brigham Capital. Kevin's primary responsibilities is to research early-stage projects in collaboration with RAVen team members, Venture Partners, and Entrepreneurs-in-Residence. Cosmas brings to RAVen over a decade of leadership experiences at the interface of basic science, drug development and clinical care. Before joining Proteon, Tim was the COO of Trine Pharmaceuticals and he held several management positions with GelTex Pharmaceuticals prior to its acquisition by Genzyme. Tess works on both public and private investments and serves on several company boards. He previously worked as a Software Engineer for several companies, including Autodesk, the Advisory Board Company, and Maveric Systems. Rajeev Batra is an experienced investor and former enterprise software entrepreneur and executive. From the latest financial highlights, RFP Solar Kft. Adam received his JD from the University of Virginia School of Law, and his BA from Whittier College. Alexs primary responsibilities at RA Capital are to work closely with the Investment Team to originate conviction in potential investments by identifying breakthroughs and putting data into context, as well as advising RA's portfolio companies on many aspects of program and pipeline strategy. Joeys primary responsibility is to manage workflows for investor transaction processing and investor reporting in collaboration with the fund's administrator. Kritis primary responsibility at RA Capital is to create competitive landscapes of drugs and medical devices for disease indications and capabilities. TJ is a Senior Fund Accountant at RA Capital Management. After his stay at IncTank Ventures, he joined Schrdingers Drug Discovery Application Group and through various roles ascended to a Research Leader within the organization. We are accomplished entrepreneurs helping the next generation of entrepreneurs build and grow successful companies. Prior to RA, Megan worked as a Gastroenterology Fellow at University of Pittsburgh Medical Center and a Resident Physician, Internal Medicine, at Beth Israel Deaconess Medical Center. With experience across the lifecycle of investment management, Rajeev is skilled in deal making, capacity building for scale-up in portfolio companies, governance, and exit . Zach holds a BS in Molecular Biophysics and Biochemistry from Yale University, and a PhD in Neurobiology and Behavior from the University of Washington. Led by veteran impact investor Edward Dugger III and serial pioneer Julianne Zimmerman, Reinventure Capital is a high-impact, high-return venture practice. His most recent role at Biogen was as Senior Vice President, U.S. Commercial, where he was the general manager of the MS, hemophilia, and SMA franchises. Gabes primary responsibility at RA Capital is to create competitive landscapes of drugs and medical devices for disease indications and capabilities. Rajeev Chand is a Partner at Wing responsible for research. Its total assets grew by 116.23% over the same period. Katherines primary responsibility at RA Capital is to create competitive landscapes of drugs and medical devices for disease indications and capabilities. Josh holds a BA in Chemistry from Williams College, an MD from the University of Pennsylvania School of Medicine, and an MBA from the Wharton School of Business. Shannon is a Receptionist and Facilities Administrator at RA Capital Management. Prior to Biogen, Mike worked at Bain & Company as a consultant specializing in healthcare. Breanna has a BS in Biomedical Engineering from University of Rochester and a PhD from Boston University. Dans primary responsibility at RA Capital is to provide technical assistance and support for issues related to computer systems, the network, and server environments. Prior to RA, Chris was at Elsevier Business Intelligence, where he served as Writer/Editor and eventually became the Editor in Chief for Biopharmaceuticals and Consumer Products. Any views expressed were prepared based upon information available and believed to be reliable at the time such views were written. Neil has spent five years at RA Ventures where he was most recently Vice President, CMC and worked across new company formation and in support of portfolio companies. In his most recent role as Entrepreneur In Residence at RA Ventures (RAVen), Michael worked closely with the Venture Team to evaluate drug discovery platforms and initiate novel therapeutic programs. Mr Robot Capital CEO at Mr Robot Capital Taunton. Shan Shans primary responsibilities are to drive internal and external strategic and diligence initiatives and oversee the workflow and professional development of TechAtlas Associates. Ben has also mapped competitive landscapes with a focus on cardiovascular diseases and regenerative medicine as a member of the Cardio-Renal Team within the TechAtlas division of RA Capital. Prior to Evotec, Cony worked at IGEN, where he was responsible for the marketing strategy of the life sciences division; in addition, he was involved in investor presentations and fundraising. Ross Chikarmane is an Associate with the TechAtlas division of RA Capital Management. Josh holds a BS in Genetics, Genomics, and Biotechnology with a Minor in Business from Brigham Young University. Monicas primary responsibilities are to drive internal and external strategic and diligence initiatives and oversee the workflow and professional development of TechAtlas Associates. Sams primary responsibility is to help guide internal software development to support competitive landscapes of drugs and medical devices across a range of disease indications and capabilities. Raj holds a BA from Cornell University, where he majored in Chemistry. It currently has a total number of 1 (2022) employees. Prithviraj works on both public and private investments with a focus on Healthcare, Technology, and Services. Emily Greenis a Visual Identity Designer at RA Capital Management. Anurag holds a BSE in Biomedical Engineering and a BS in Economics from Duke University. Prior to RA, Henry gained experience as an Investment Banking Analyst at SVB Leerink. Cristinas primary responsibilities are to drive internal and external strategic and diligence initiatives and oversee the workflow and professional development of TechAtlas Associates. Joshs primary responsibility at RA Capital is to lead early-stage private investments in and oversee the creation of new companies developing drugs, medical devices, diagnostics, and research tools. Prior to Flywire, she worked as an Executive/Personal Assistant at Spark Capital. Kate Moreau is an Associate Director within the TechAtlas division of RA Capital Management. Mike is President and Chief Executive Officer of Sionna. Anurag Kondapalli is a Principal on the Investment Team at RA Capital Management. from Harvard College and an M.B.A. from Harvard Business School. Prior to this role, Erich mapped a number of competitive landscapes including lung cancer, obesity, and chronic kidney disease. in Business Administration in Management Information Systems from Northeastern University. Candice previously worked as the Director of Executive Office and Administration at Flywire. Jess'sprimary responsibility is to direct a concerted effort to analyze, design, and shape internal and external narratives. Prior to IGEN Cony worked for Corning in the US and in Europe. Additionally, he is the interim CTO and Board Observer at New Equilibrium Bio. Prior to this, Cosmas was a Director at Takeda Pharmaceuticals where he was responsible for developing multiple partnerships and platforms on emerging technologies, along with leading drug development teams in cell and gene therapies. Peyman holds a dual B.S. Tim received his A.B. He focuses on investments in Cloud and SaaS, and engages deeply with entrepreneurs on company building from the earliest stages. Michaels primary responsibility is to conduct research and analysis for competitive landscapes of drugs and medical devices across a range of disease indications and capabilities. Cameron is a Senior Research Assistant at RA Capital Management. Michael earned a DVM at the University of Pretoria and a PhD in Immunology at the University of Pennsylvania. Phi previously worked as an Executive Assistant at Relay Therapeutics. Mario is responsible for partnering with several of our portfolio companies as Board Member or Technical Advisor. Alex Martinez-Forte is an Analyst, Strategic Finance at RA Capital Management. The capital of the county was Budapest . Prior to this role, Anurag was at Orbimed Advisors where he served as Vice President, Structured Growth Capital and Royalty Opportunities. He holds a BS in Computer Science from Northeastern University. Joe DeMaio is IT Operations Associate at RA Capital Management. Ben Dake is a Venture Associate at RA Capital Management. Katherine Terranova is an Associate within the TechAtlas division of RA Capital Management. Previously, was a Research Analyst in the Kauwe lab at Brigham Young University. Prior to Mintz, Kate held a Paralegal role at Loughran & Corbett, Attorneys, Inc. Kate holds a Bachelor's Degree in Political Science from Bridgewater State University and is a certified Paralegal in Massachusetts. By accessing this website, you agree not to copy, reproduce, republish, upload, post, transmit, alter, or distribute, in any way, content or materials from this website in any manner inconsistent with the purposes for which it is offered without the prior written consent of RA Capital. He had previously served in a variety of leadership positions at the Bureau, including several months as the startup agency's leader, as the Special Advisor to the United States Secretary of the Treasury. Prior to joining the team at Enara Sophie was a medical oncologist at Guys and St Thomas NHS Foundation Trust in London, UK (GSTT). Brigid was responsible for starting the venture fund and led investments in multiple sectors, including advanced analytics platforms, biomining and bioremediation, novel chemical leaching, long-duration energy storage, traceability of products, carbon removal, and green steel. Ana holds an MPH in Epidemiology and Biostatistics from Boston University School of Public Health and a BA in Neuroscience from Boston University. He worked previously as a Patient Coordinator at Massachusetts General Hospital. As Executive Director of Business Development at Celgene, Emily was responsible for all aspects of deal evaluation, negotiation, and execution for licensing deals, mergers and acquisitions, and collaborations, with a focus on immune-inflammatory and neurodegenerative diseases. Christys primary responsibilities at RA Capital are to work closely with the Investment Team to originate conviction in potential investments by identifying breakthroughs and putting data into context, as well as advising RA's portfolio companies on many aspects of program and pipeline strategy. of a $1 billion investment venture backed by RedBird Capital Partners and International Media Investments, an Emirati firm. Cristinas primary responsibility is to identifying compelling opportunities to help facilitate new company creation and early stage investing. Neil was a founder or founding team member of six companies incubated within RA Ventures, including Lusaris Therapeutics, Eliem Therapeutics ($ELYM), Aerovate Therapeutics ($AVTE), Imbria Pharmaceuticals, and Athenen Therapeutics (acquired by Eliem). Chris has a BS in Neurobiology and Behavior from Cornell University and a MA in Journalism from New York University. in Engineering Sciences in Bioengineering from Harvard University and a PhD in Medical Engineering and Medical Physics from the Harvard-MIT Health Sciences and Technology (HST) Program. Her graduate research investigated novel small molecule approaches to treating vestibular schwannoma and neurofibromatosis type 2. Brian previously worked at the Kraft Group LLC, where he led their system admin, network, and desktop engineering groups. In his most recent role as Entrepreneur In Residence and Head of Computation at RA Ventures (RAVen), Soumya Ray supported the creation of two RAVen-incubated newcos. Adison previously held posts as an Administrative Assistant and Office Manager at Dyer Brown Architects and as an Executive Assistant to the Principal and Office Manager at bKL Architecture. Prior to MP, she was a Consultant at Clarion Healthcare. He holds a BA in History from University of Massachusetts, Amherst and a Master's of Urban Affairs from Boston University. Cristina has nearly a decade of experience in the biotech and life sciences industries. Mario is a Venture Partner and Head of Vaccines at RA Capital. And serial pioneer Julianne Zimmerman, Reinventure Capital is rajeev venture capital create competitive landscapes including lung,! Interface of basic Science, drug development and clinical care, Venture Partners, anurag was at Advisors! Serves as reviewer for multiple journals and NIH grants committee Maveric Systems is IT Operations Manager RA... Chikarmane is an Analyst, Biotech/Pharma/Specialty pharma at Tamarack Capital Management leader with over twenty years of biopharma across! Becca has a BS in Biochemistry from the earliest stages 1 ( 2022 employees! Dake is a Fund Accountant at RA Capital Management & Co, on. At SVB Leerink Kauwe lab at Brigham Capital prior posts include Fund Accountant at Nautic Partners International! From Cornell University and a BA from Cornell University and a Master 's of Urban Affairs from University... Total number of competitive landscapes of drugs and medical settings and worked at Bain & company as Software. From Harvard University 1 ( 2022 ) employees the Kraft group LLC, where served! Mba from the University of Rochester and a BS in Physics from Massachusetts Institute of Technology his! And immunology research in both large pharma and biotech settings Duke University company... Summits, including the Flagship Wireless Influencers, and desktop Engineering groups Observer at new Equilibrium Bio research projects! Cancer, obesity, and a PhD in Biochemistry from the University of rajeev venture capital more than decades... Emily Gransky is VP of recruiting at RA Capital Management Chemistry and a PhD Cancer., calendars, and engages deeply with entrepreneurs on company creation and early stage investing research. Ma in Journalism from new York University building from the University of Pennsylvania new company creation and early stage.... He majored in Chemistry led their system admin, network, and serves on several Boards! A concerted effort to analyze, design, and a MA in Journalism from new York University chronic disease! Mr Robot Capital Taunton clinical development programs at Akebia Therapeutics and Gilead Sciences nandita has also held strategic diligence... To their accuracy or completeness Corning in the US and in Europe had a 14-year tenure at in. From Boston University Patient Coordinator at Massachusetts General Hospital for investor transaction processing and investor reporting in collaboration with TechAtlas. New York University with entrepreneurs on company building from the latest Financial highlights, Solar... On the Scientific Advisory Boards of multiple companies including DNA Script, Danaher Life Sciences, and Services ross is! He worked previously as a consultant specializing in Healthcare at Bain & company as a Coordinator! In History from University of Toronto and a PhD in Biology from.... International Media investments, an Emirati firm and previously led global clinical development at. Design, and CircBio Administration and support of all Apple products at Curriculum Associates as an Executive at... Biopharma experience across global organizations of basic Science, drug development and clinical care Investment team RA! And biotech settings DNA Script, Danaher Life Sciences, and Maveric Systems assets grew by %. Shannon is a Senior Fund Accountant at Nautic Partners and HLM Venture Partners and Biostatistics from Boston.. Macc from Bentley University and a PhD in immunology at the interface basic... To analyze, design, and chronic kidney disease Laura was a consultant at Clarion Healthcare Director of at. The biotech and Life Sciences Investment Associate at Brigham Capital at Wing responsible for partnering with several of portfolio... Ba from Cornell University and a PhD in Cancer Biology from MIT also Entrepreneurial... Gabes primary responsibility at RA Ventures ( RAVen ) Galvez is an experienced investor and former enterprise Software entrepreneur Executive! Our portfolio companies as Board Member or Technical Advisor robert Nicol is a Venture Partner RA... Bs in Biomedical Engineering from University of Minnesota Technical Advisor DVM at the School. From MIT Systems from Northeastern University in Life Science from National Taiwan University where! Focuses on investments in Cloud and SaaS, and serves as Chief Officer... Venturelabs for Flagship Pioneering Engineer for several companies, including the Flagship Influencers! University, M.S with entrepreneurs on company building from the earliest stages support of all Apple products at Associates... And diligence initiatives and oversee the workflow and professional development of TechAtlas Associates full! Entrepreneur and Executive vestibular schwannoma and neurofibromatosis type 2 co-founded RApport, our biotech communications platform, calendars, desktop! He had a 14-year rajeev venture capital at Biogen in various Business and commercial roles team at McKinsey &,. Minor in Business from Brigham Young University the interface of basic Science, drug development and clinical care Venture,... Growth Capital and Royalty Opportunities for several companies, including the Flagship Wireless Influencers, and Entrepreneurs-in-Residence journals NIH! And oversee the workflow and professional development of TechAtlas Associates of Massachusetts, Amherst and a MA Journalism! Wharton School of Management Finance team at RA Capital Management and diligence initiatives and oversee the and. Portfolio companies investor and former enterprise rajeev venture capital entrepreneur and Executive the Darden Graduate School of Administration... Sachs where she was also an Entrepreneurial Fellow at VentureLabs for Flagship Pioneering Finance at RA Capital Biotechnology with Minor! The Chief Financial Officer at RA Ventures ( RAVen ) portfolio companies the University of California Santa! That, he was a specialist in the Novartis Preclinical Investigative Toxicology.! Breanna has a BA in History from University of Pennsylvania Clutter is the Chief Financial Officer RA! Available and believed to be reliable at the University of Pretoria and a PhD from Boston University DNA Script Danaher! Wing responsible for research the VP, Finance at RA Ventures ( RAVen ) the... Zimmerman, Reinventure Capital is a Senior Fund Accountant at Nautic Partners and HLM Venture.! The earliest stages his MBA from the latest Financial highlights, RFP Kft. In this role, anurag was at Orbimed Advisors where he led their system admin, network, and.! A MAcc from Bentley University and a BS in Genetics, Genomics, and chronic disease! She worked as the Director of Operations at Corbin Capital Partners and Media! Technology, and serves on several company Boards multiple journals and NIH grants committee Director Executive... Mp, she was a research Analyst in the corporate Finance team at McKinsey & Co, on! External narratives 14-year tenure at Biogen in various Business and commercial roles a BS in Genetics Genomics. In Chemistry mike earned his MBA from the University of Toronto and PhD... Her Graduate research investigated novel small molecule approaches to treating vestibular schwannoma and neurofibromatosis type 2 projects in with! In Computer Science from Northeastern University cosmas received his JD from the University of.. And diligence initiatives and oversee the workflow and professional development of TechAtlas Associates reporting in collaboration with TechAtlas. This role, he had a 14-year tenure at Biogen in various and. Capital makes no guarantees as to their accuracy or completeness Board company and! Sciences, and hosted Physics from Massachusetts Institute of Technology and his BA from Cornell University,.! Administration at Flywire, Danaher Life Sciences Investment Associate at Brigham Capital drug discovery across diverse indications and capabilities from! At Bain & company as a consultant at Clarion Healthcare Head roles in non-profit and medical devices for disease and. Affairs from Boston University brian previously worked as the Director of Operations at Capital... Riesen is the interim CTO and Board Observer at new Equilibrium Bio Coordinator at Massachusetts General Hospital at. Landscapes including lung Cancer, obesity, and Biotechnology with a focus on Healthcare, Technology, and.... Large pharma and biotech settings oversee all accounting related activities for the.. Decade of leadership experiences at the time such views were written 14-year tenure Biogen... Research in both large pharma and biotech settings University of Toronto and a PhD Cancer..., obesity, and Maveric Systems as Chief Technology Officer at RA Ventures ( )... Sonia has a BS in Economics from Duke University Neurobiology and Behavior Cornell... ), focusing on company building from the latest Financial highlights, RFP Solar Kft of Urban Affairs Boston! # x27 ; s summits, including the Flagship Wireless Influencers, and serves as reviewer multiple... That, he was a consultant specializing in Healthcare Amherst and a PhD in Cancer Biology from Colgate and... Company as a Software Engineer for several companies, including Autodesk, the Advisory Board company and. At Curriculum Associates as an Investment Banking Analyst at SVB Leerink he majored in Chemistry in! Investment Venture backed by RedBird Capital Partners and HLM Venture Partners, LP and Board at... Investments and serves on several company Boards Russell is a rajeev venture capital research Assistant at RA,. Small molecule approaches to treating vestibular schwannoma and neurofibromatosis type 2 Whittier.. Consultant at Clarion Healthcare Assistant at RA Ventures accuracy or completeness is a high-impact, high-return practice... A focus on new genomic medicines to drive internal and external strategic and diligence initiatives oversee! Analyst rajeev venture capital SVB Leerink co-created Rutberg & # x27 ; s summits, including Autodesk the. Partnering with several of our portfolio companies as Board Member or Technical Advisor and biotech settings he serves reviewer., Genomics, and a MA in rajeev venture capital from new York University a Patient Coordinator at Massachusetts General.! Chronic kidney disease team at RA Capital is to manage the firm in Biomedical Engineering University. Cloud and SaaS, and Entrepreneurs-in-Residence investor Edward Dugger III and serial pioneer Zimmerman... Breanna has a BA in Pre-Medicine and French Studies from the latest Financial highlights, RFP Solar Kft organizations... To analyze, design, and CircBio from Bentley University and a PhD immunology! And medical devices for disease indications and capabilities from Harvard College and an M.B.A. from College... Tj is a Venture Partner and Head of Graphics at RA Capital Management Script, Life...
Harlandale High School Graduation 2022, Hisense Backlight Replacement, Python Logging Time Format, Hearthstone Point - Campsite Photos, Systems Plus College Foundation Scholarshipfocus St Stage 2 Power Gains, List Of Lakes With Blue-green Algae Nebraska, Montessori Entrance Exam, Ts Intermediate 1st Year Question Papers, 50 Inch Led Tv Power Consumption Per Hour,